NASDAQ: QLI - Qilian International Holding Group Limited

الربحية لمدة ستة أشهر: -10.14%
عائد الأرباح: 0.00%
قطاع: Healthcare

جدول الترويج Qilian International Holding Group Limited


عن الشركة Qilian International Holding Group Limited

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.

مزيد من التفاصيل
It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.

IPO date 2021-01-12
ISIN KYG7307E1070
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Дивиденд ао 0.25
Сайт https://ir.qlsyy.net
Цена ао 7.18
تغير السعر يوميا: 0% (7.18)
تغير السعر في الأسبوع: 0% (7.18)
تغير السعر شهريا: 0% (7.18)
تغير السعر خلال 3 أشهر: 0% (7.18)
تغير السعر على مدى ستة أشهر: -10.14% (7.99)
تغير السعر سنويا: +940.58% (0.69)
تغير السعر على مدى 3 سنوات: +310.29% (1.75)
تغير الأسعار منذ بداية العام: 0% (7.18)

الاستهانة

اسم معنى درجة
P/S 2.96 6
P/BV 3.09 5
P/E 127.83 1
EV/EBITDA -89.12 0
المجموع: 3.88

كفاءة

اسم معنى درجة
ROA, % -15.18 0
ROE, % -18.18 0
المجموع: 0

توزيعات الأرباح

اسم معنى درجة
Div yield, % 0 0
DSI 0.5 5
المجموع: 3.57

واجب

اسم معنى درجة
Debt/EBITDA -0.3939 10
المجموع: 8.2

دافع النمو

اسم معنى درجة
الربحية Revenue, % 0.8058 1
الربحية Ebitda, % -117.46 0
الربحية EPS, % -242.81 0
المجموع: 2.2

المؤسسات مقدار يشارك, %
Geode Capital Management, LLC 23641 0.07
UBS Group AG 3357 0.01
Morgan Stanley 1794 0.01



مشرف مسمى وظيفي قسط سنة الميلاد
Mr. Zhanchang Xin Chairman of the Board, President, COO & Chief Scientific Officer 17.94k 1967 (58 سنين)
Mr. Chen Xin Chief Executive Officer 1993 (32 سنة)
Ms. Yaxuan Zhai Chief Financial Officer 1995 (30 سنين)

عنوان: China, Jiuquan, Jiuquan Economic and Technological Development Zone - مفتوحة في خرائط جوجل, فتح خرائط ياندكس
موقع إلكتروني: https://ir.qlsyy.net